Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria

被引:2
|
作者
Tomita, Akihiro [1 ]
Shirasugi, Yukari [2 ]
Ito, Takahiko [3 ]
Tsurumi, Hisashi [4 ]
Naoe, Tomoki [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Tokai Univ Hosp, Dept Hematol & Oncol, Isehara, Kanagawa, Japan
[3] Gifu Social Insurance Hosp, Dept Hematol, Kani, Japan
[4] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
关键词
Hemolytic Anemia; Paroxysmal Nocturnal Hemoglobinuria; Eculizumab; Hemoglobinuria; Intravascular Hemolysis;
D O I
10.1007/s00277-011-1368-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1139 / 1141
页数:3
相关论文
共 50 条
  • [21] Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
    Fassett, Michael J.
    Lopez, Adrian L. Hernandez
    CASE REPORTS IN WOMENS HEALTH, 2021, 30
  • [22] Fanconi syndrome and chronic kidney disease in paroxysmal nocturnal hemoglobinuria: effect of eculizumab therapy
    Moumas, Eric
    Bridoux, Frank
    Leroy, Fannie
    Belmouaz, Simohamed
    Randriamalala, Edouard
    Desport, Estelle
    Dreyfus, Brigitte
    Delbes, Sebastien
    Quellard, Nathalie
    Touchard, Guy
    CLINICAL NEPHROLOGY, 2012, 78 (04) : 316 - 321
  • [23] Paroxysmal nocturnal hemoglobinuria: Test to monitor the action of eculizumab treatment
    Arcavi, Miriam
    Ceballo, Fernanda
    Caracciolo, Maria Beatriz
    Lazarowski, Alberto
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (03) : 335 - 340
  • [24] Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Kulagin, Alexander D.
    Ptushkin, Vadim V.
    Lukina, Elena A.
    Davydkin, Igor L.
    Korobkin, Alexander V.
    Konstantinova, Tatiana S.
    Komartseva, Elena Yu.
    Minaeva, Natalia V.
    Mitina, Tatiana A.
    Klimova, Olesya U.
    Arshanskaya, Evgeniya G.
    Latyshev, Vitalii D.
    Markova, Oksana A.
    Zuev, Eugene V.
    ACTA HAEMATOLOGICA, 2024,
  • [25] Erythropoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria
    Hill, A.
    Richards, S. J.
    Rother, R. P.
    Hillmen, P.
    HAEMATOLOGICA, 2007, 92 (03) : E31 - E33
  • [26] Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab
    Krishnan, Suresh K.
    Hill, Anita
    Hillmen, Peter
    Arnold, Louise M.
    Brooksbank, Gemma L.
    Wood, Alex
    Scarsbrook, Andrew
    Davies, Mervyn H.
    Kelly, Richard J.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) : 716 - 718
  • [27] Atypical presentation of paroxysmal nocturnal hemoglobinuria treated by eculizumab
    Quinquenel, Anne
    Maestraggi, Quentin
    Lecoq-Lafon, Carinne
    Regis, Peffault de Latour
    Delmer, Alain
    Servettaz, Amelie
    MEDICINE, 2017, 96 (12)
  • [28] Evaluation of the use of eculizumab for treatment of paroxysmal nocturnal hemoglobinuria
    Maria de Andres, Ana
    Sola, Nuria
    Creus, Natalia
    Codina, Carles
    Ribas, Josep
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 299 - 300
  • [29] Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes
    Ilic, Jovanka
    Pujic, Borislava
    Jakovljevic, Branislava
    Sekulic, Borivoj
    Agic, Danijela
    El Farra, Amir
    Micanovic, Branimir
    Vejnovic, Tihomir
    Urosevic, Ivana
    Savic, Aleksandar
    CLINICAL CASE REPORTS, 2024, 12 (05):
  • [30] Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria
    Seiko Iki
    Kazuyuki Ohgi
    Kenshi Suzuki
    International Journal of Hematology, 2017, 105 : 231 - 232